Ask Warren

Chabiotech

085660 · KOSDAQ · ₩085660 · 차바이오텍

₩6,750▼ ₩10 (0.15%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩1.3T₩1T₩954B₩845B₩727B
Cost of sales₩905B₩770B₩678B₩640B₩511B
Gross profit₩364B₩275B₩276B₩205B₩217B
Operating income−₩49B−₩60B−₩9.6B−₩47B₩7.7B
Net income−₩147B−₩15B−₩5.6B−₩70B−₩22B
Net income to shareholders−₩110B−₩8.1B−₩8.4B−₩48B−₩14B

Balance sheet

20252024202320222021
Total assets₩2.5T₩2.2T₩1.7T₩1.6T₩1.5T
Current assets₩888B₩734B₩538B₩520B₩577B
Cash and equivalents₩238B₩235B₩61B₩67B₩123B
Total liabilities₩1.7T₩1.5T₩1.1T₩955B₩742B
Current liabilities₩1.3T₩1T₩646B₩478B₩422B
Borrowings₩818B₩656B₩395B₩346B₩291B
Total equity₩809B₩719B₩656B₩652B₩793B
Shareholders' equity₩305B₩285B₩281B₩292B₩456B

Cash flow

20252024202320222021
Cash from operations−₩73B−₩50B₩12B−₩21B₩22B
Capital spending₩147B₩94B₩70B₩120B₩113B
Free cash flow−₩220B−₩143B−₩59B−₩141B−₩90B
Dividends paid−₩1.5B−₩1.3B−₩1.5B−₩1.2B−₩4B

Consolidated where available. Amounts in won.

Also known as: Chabiotech / 차바이오텍 / 085660 / KRX:085660

Source: KRX statistical information